Search - tctmd.com

Displaying 301 - 320 of 1577

Sort: Relevancy | Date

US, European Hypertension Guidelines: More Alike Than Different

News Daily News

US, European Hypertension Guidelines: More Alike Than Different

August 17, 2022

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

News Daily News

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Yael L. Maxwell

August 16, 2022

CASSISS: No Benefit of Stenting for Intracranial Stenosis

News Daily News

CASSISS: No Benefit of Stenting for Intracranial Stenosis

August 12, 2022

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

News Daily News

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

August 12, 2022

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

RESCUE BT: IV Tirofiban No Help During Stroke Thrombectomy

News Daily News

RESCUE BT: IV Tirofiban No Help During Stroke Thrombectomy

August 09, 2022

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

News Daily News

Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression

Michael O'Riordan

August 08, 2022

Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysis

News Daily News

Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysis

August 02, 2022

Peridevice Leaks After LAA Occlusion Signal Poorer 5-Year Outcomes

News Daily News

Peridevice Leaks After LAA Occlusion Signal Poorer 5-Year Outcomes

July 28, 2022

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

News Daily News

USPSTF Recommends Behavior Counseling to Improve Diet and Exercise Habits

Michael O'Riordan

July 27, 2022

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

July 25, 2022

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

July 20, 2022

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

News Daily News

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Michael O'Riordan

July 06, 2022

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

News Daily News

Warfarin May Speed Progression of Aortic Stenosis and Worsen Outcomes

July 04, 2022

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

June 10, 2022

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

News Daily News

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

June 06, 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

May 22, 2022

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

News Daily News

Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS

May 10, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.